Prolife Pharma B.V as a European company has its own Pharmacovigilance system , monitored and controlled by EU Qualified teams for Pharmacovigilance (QPPV)
The EU Pharmacovigilance system
All medicinal products in the EU are subject to a strict testing and assessment of their quality, efficacy and safety before being authorised. Once placed on the market they continue to be monitored so to assure that any aspect which could impact the safety profile of a medicine is detected and assessed and that necessary measures are taken. This monitoring is called Pharmacovigilance.
for more information ….>>>>